RLIP76 Gene Variants are not Associated with Drug Response in Turkish Epilepsy Patients

Sillanpää M, Schmidt D. Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study. Brain. 2006; 129(Pt. 3): 617-624.10.1093/brain/awh72616401617Search in Google Scholar

Steinlein OK. Gene polymorphisms and their role in epilepsy treatment and prognosis. Naunyn Schmiedebergs Arch Pharmacol. 2010; 382(2): 109-118.10.1007/s00210-010-0531-820556360Search in Google Scholar

Sisodiya SM, Marini C. Genetics of antiepileptic drug resistance. Curr Opin Neurol. 2009; 22(2): 150-156.10.1097/WCO.0b013e32832923ec19532038Search in Google Scholar

Awasthi S, Hallene KL, Fazio V, Singhal SS, Cucullo L, Awasthi YC, Dini G, Janigro D. RLIP76, a non-ABC transporter, and drug resistance in epilepsy. BMC Neurosci. 2005; 6: 61.10.1186/1471-2202-6-61124957916188027Search in Google Scholar

Jullien-Flores V, Dorseuil O, Romero F, Letourneur F, Saragosti S, Berger R, Tavitian A, Gacon G, Camonis JH. Bridging Ral GTPase to Rho pathways. RLIP76, a Ral effector with CDC42/Rac GTPase-activating protein activity. J Biol Chem. 1995; 270(38): 22473-22477.10.1074/jbc.270.38.224737673236Search in Google Scholar

Awasthi S, Singhal SS, Sharma R, Zimniak P, Awasthi YC. Transport of glutathione conjugates and chemotherapeutic drugs by RLIP76 (RALBP1): a novel link between G-protein and tyrosine kinase signaling and drug resistance. Int J Cancer. 2003; 106(5): 635-646.10.1002/ijc.1126012866021Search in Google Scholar

Sharma R, Singhal SS, Cheng J, Yang Y, Sharma A, Zimniak P, Awasthi S, Awasthi YC. RLIP76 is the major ATP-dependent transporter of glutathione-conjugates and doxorubicin in human erythrocytes. Arch Biochem Biophys. 2001; 391(2): 171-179.10.1006/abbi.2001.239511437348Search in Google Scholar

Rossé C, L'Hoste S, Offner N, Picard A, Camonis J. RLIP, an effector of the Ral GTPases, is a platform for Cdk1 to phosphorylate epsin during the switch off of endocytosis in mitosis. J Biol Chem. 2003; 278(33): 30597-30604.10.1074/jbc.M30219120012775724Search in Google Scholar

Singhal SS, Yadav S, Singhal J, Awasthi YC, Awasthi S. Mitogenic and drug-resistance mediating effects of PK-Calpha require RLIP76. Biochem Biophys Res Commun. 2006; 348(2): 722-727.10.1016/j.bbrc.2006.07.118291668216890208Search in Google Scholar

Awasthi S, Singhal SS, Yadav S, Singhal J, Vatsyayan R, Zajac E, Luchowski R, Borvak J, Gryczynski K, Awasthi YC. A central role of RLIP76 in regulation of glycemic control. Diabetes. 2010; 59(3): 714-725.10.2337/db09-0911282864520007934Search in Google Scholar

Soranzo N, Kelly L, Martinian L, Burley MW, Thom M, Sali A, Kroetz DL, Goldstein DB, Sisodiya SM. Lack of support for a role for RLIP76 (RALBP1) in response to treatment or predisposition to epilepsy. Epilepsia. 2007; 48(6): 674-683.10.1111/j.1528-1167.2007.00926.x17437410Search in Google Scholar

Leschziner GD, Jorgensen AL, Andrew T, Williamson PR, Marson AG, Coffey AJ, Middleditch C, Balding DJ, Rogers J, Bentley DR, Chadwick D, Johnson MR, Pirmohamed M. The association between polymorphisms in RLIP76 and drug response in epilepsy. Pharmacogenomics. 2007; 8(12): 1715-1722.10.2217/14622416.8.12.171518086001Search in Google Scholar

Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16(3): 1215.10.1093/nar/16.3.12153347653344216Search in Google Scholar

Alper OM, Erengin H, Manguoğlu AE, Bilgen T, Cetin Z, Dedeoğlu N, Lüleci G. Consanguineous marriages in the province of Antalya, Turkey. Ann Genet. 2004; 47(2): 129-138.10.1016/j.anngen.2003.09.00115183745Search in Google Scholar

Janigro D, Awasthi S, Awasthi YC, Sharma R, Yadav S, Singhal SS, Hallene K. RLIP76 in AED drug resistance. Epilepsia. 2007; 48(6): 1218-1219.10.1111/j.1528-1167.2007.01155_4.x17553125Search in Google Scholar

Sisodiya S, Thom M. Response to Janigro et al. Epilepsia. 2007; 48(6): 219-220.10.1111/j.1528-1167.2007.01155_5.xSearch in Google Scholar

Löscher W, Klotz U, Zimprich F, Schmidt D. The clinical impact of pharmacogenetics on the treatment of epilepsy. Epilepsia. 2009; 50(1): 1-23.10.1111/j.1528-1167.2008.01716.x18627414Search in Google Scholar

Haerian BS, Roslan H, Raymond AA, Tan CT, Lim KS, Zulkifli SZ, Mohamed EH, Tan HJ, Mohamed Z. AB-CB1 C3435T polymorphism and the risk of resistance to antiepileptic drugs in epilepsy: a systematic review and meta-analysis. Seizure. 2010; 19(6): 339-346.10.1016/j.seizure.2010.05.00420605481Search in Google Scholar

Zhang C, Kwan P, Zuo Z, Baum L. In vitro concentration dependent transport of phenytoin and phenobarbital, but not ethosuximide, by human P-glycoprotein. Life Sci. 2010; 86(23-24): 899-905.10.1016/j.lfs.2010.04.00820417647Search in Google Scholar

Rivers F, O'Brien TJ, Callaghan R. Exploring the possible interaction between antiepilepsy drugs and multi-drug efflux pumps; in vitro observations. Eur J Pharmacol. 2008; 598(1-3): 1-8.10.1016/j.ejphar.2008.09.01418835265Search in Google Scholar

Luna-Tortós C, Fedrowitz M, Löscher W. Evaluation of transport of common antiepileptic drugs by human multidrug resistance-associated proteins (MRP1, 2 and 5) that are overexpressed in pharmacoresistant epilepsy. Neuropharmacology. 2010; 58(7): 1019-1032.10.1016/j.neuropharm.2010.01.00720080116Search in Google Scholar

Sánchez MB, Herranz JL, Leno C, Arteaga R, Oterino A, Valdizán EM, Nicolás JM, Adín J, Armijo JA. Genetic factors associated with drug-resistance of epilepsy: relevance of stratification by patient age and aetiology of epilepsy. Seizure. 2010; 19(2): 93-101.10.1016/j.seizure.2009.12.00420064729Search in Google Scholar

Berg AT. Identification of pharmacoresistant epilepsy. Neurol Clin. 2009; 27(4): 1003-1013.10.1016/j.ncl.2009.06.001282718319853220Search in Google Scholar

Viteva EI, Zahariev ZI. Pseudoresistance in patients with epilepsy characteristics and determining factors. Folia Med (Plovdiv). 2009; 51(2): 33-39.Search in Google Scholar

Kim WJ, Lee JH, Yi J, Cho YJ, Heo K, Lee SH, Kim SW, Kim MK, Kim KH, Lee BI, Lee MG. A nonsynonymous variation in MRP2/ABCC2 is associated with neurological adverse drug reactions of carbamazepine in patients with epilepsy. Pharmacogenet Genom. 2010; 20(4): 249-256.10.1097/FPC.0b013e328338073a20216337Search in Google Scholar

Canevini MP, De Sarro G, Galimberti CA, Gatti G, Licchetta L, Malerba A, Muscas G, La Neve A, Striano P, Perucca E, and the SOPHIE Study Group. Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy. Epilepsia. 2010; 51(5): 797-804.10.1111/j.1528-1167.2010.02520.x20545754Search in Google Scholar